Ironwood Pharmaceuticals, Inc. Class A IRWD
NASDAQ · United States · Health Technology
$3.76-0.21 (-5.29%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | 0.31 | 0.32 | -3.1% | $113.04M | -1.6% | +4.1%$4.15→$4.32 |
| Q1 2026 | 2026-05-07 | 0.24 | 0.07 | +242.9% | — | — | -12.6%$4.83→$4.22 |
| Q4 2025 | 2026-02-25 | -0.01 | 0.01 | -200.0% | — | — | -3.4%$3.79→$3.66 |
| Q3 2025 | 2025-11-10 | 0.24 | 0.12 | +100.0% | — | — | +50.5%$1.92→$2.89 |
| Q4 2024 | 2025-02-27 | 0.02 | 0.08 | -75.0% | — | — | — |
| Q1 2024 | 2024-05-09 | -0.02 | 0.15 | -113.3% | — | — | — |
| Q4 2023 | 2024-02-15 | 0.00 | 0.20 | -100.0% | — | — | — |
| Q3 2023 | 2023-11-09 | 0.12 | 0.16 | -25.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.